Efficient no-code solution with its own IDE for easier development.

These entrants are competing with far bigger players, including OpenAI, Anthropic, and Microsoft, that make their own ...

Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, announced today that the U.S. Food ...